Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Synovial × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 90 Leukemia 36 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Myelodysplastic Syndromes 15 Leukemia, Monocytic, Acute 14 Leukemia, Myelomonocytic, Acute 13 Leukemia, Erythroblastic, Acute 12 Leukemia, Megakaryoblastic, Acute 11 Congenital Abnormalities 11 Recurrence 8 Leukemia, Promyelocytic, Acute 8 Carcinoma, Hepatocellular 7 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Biphenotypic, Acute 6 Anemia, Refractory, with Excess of Blasts 5 Myeloproliferative Disorders 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Neoplasm, Residual 3 Lymphoma 3 Liver Neoplasms 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Eosinophilic, Acute 3 Leukemia, Basophilic, Acute 3 Blast Crisis 3 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, T-Cell 2 Graft vs Host Disease 2 Thrombocythemia, Essential 1

Interventions

Cyclophosphamide 9 fludarabine 5 Doxorubicin 5 Radiotherapy 4 Gemcitabine 3 sargramostim 2 fludarabine phosphate 2 aldesleukin 2 Sunitinib 2 Radiation Dose Hypofractionation 2 Ifosfamide 2 Docetaxel 2 Dacarbazine 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 trofosfamide 1 tremelimumab 1 temsirolimus 1 sotigalimab 1 ribociclib 1 poly ICLC 1 pembrolizumab 1 pegfilgrastim 1 pazopanib 1 pasireotide 1 liposomal doxorubicin 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 itacitinib 1 durvalumab 1 baricitinib 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡